FDA Approved · October 2023 IL-17A & F Inhibitor · Dermatology · Plaque Psoriasis âš
Category: Dermatology
Difamiliast
FDA Approved · February 2026 PDE-4 Inhibitor · Dermatology · Atopic Dermatitis Difamilast ADQUEY™ ·
Deuruxolitinib
Deuruxolitinib (LEQSELVI) — TrialistMD Drug Profile TRIALISTMD · Drug Intelligence Platform FDA APPROVED 2024 JAK